Media Summary: Off-target drug binding can cause serious side effects or even death. We developed the What are the best practices when it comes to multiplexing on high surface area? This video shows you how to handle the ... ... explain antibody cross-reactivity How the

Membrane Proteome Array De Risk - Detailed Analysis & Overview

Off-target drug binding can cause serious side effects or even death. We developed the What are the best practices when it comes to multiplexing on high surface area? This video shows you how to handle the ... ... explain antibody cross-reactivity How the Rigorous specificity analysis is critical for successful drug development and a safety requirement for antibody-based therapies, ... Bio-Techne®의 공식 한국대리점인 웅비메디텍을 통해 R&D Systems®의 다양한 Multiplex 제품들을 만나보세요. ... optimize affinity, developability, and IP breadth at once, and presents

Rigorous specificity analysis is critical for successful drug development and a safety requirement for monoclonal antibody (mAb) ... Traditional pathways for antibody IND submission often overlook opportunities to mitigate ... then we keep having a bunch of additional

Photo Gallery

Membrane Proteome Array: De-risk your program by choosing the right lead molecule.
Membrane Array [How-to Handle when Multiplexing]
De-Risking Antibody Lead Selection: Is your antibody as specific as you think? by Ben Doranz, PhD
Comprehensive Specificity Profiling of Antibody-Based Therapeutics Using the Membrane Proteome Array
Specificity Testing of Antibody and CAR-T Cell Therapies for IND Using the Membrane Proteome Array
[Webinar]Towards IND: Specificity Profiling of Antibody Therapies Using the Membrane Proteome Array
Membrane Protein Identification by Shotgun Proteomics
R&D Systems®: Proteome Profiler Antibody Array 실험과정 (공식대리점: 웅비메디텍)
100+ Undruggable Targets Unlocked Through Parallel MAb Engineering
[GEN Webinars] Towards IND: Specificity Profiling of Antibody-Based Therapies
Ab Development to IND: Early Risk Mitigation, Target Specificity, & mRNA-LNP Delivery
Lecture 12, concept 05: Membrane proteins are some of the most common drug targets
View Detailed Profile
Membrane Proteome Array: De-risk your program by choosing the right lead molecule.

Membrane Proteome Array: De-risk your program by choosing the right lead molecule.

Off-target drug binding can cause serious side effects or even death. We developed the

Membrane Array [How-to Handle when Multiplexing]

Membrane Array [How-to Handle when Multiplexing]

What are the best practices when it comes to multiplexing on high surface area? This video shows you how to handle the ...

De-Risking Antibody Lead Selection: Is your antibody as specific as you think? by Ben Doranz, PhD

De-Risking Antibody Lead Selection: Is your antibody as specific as you think? by Ben Doranz, PhD

... explain antibody cross-reactivity How the

Comprehensive Specificity Profiling of Antibody-Based Therapeutics Using the Membrane Proteome Array

Comprehensive Specificity Profiling of Antibody-Based Therapeutics Using the Membrane Proteome Array

Integral Molecular has developed the

Specificity Testing of Antibody and CAR-T Cell Therapies for IND Using the Membrane Proteome Array

Specificity Testing of Antibody and CAR-T Cell Therapies for IND Using the Membrane Proteome Array

Rigorous specificity analysis is critical for successful drug development and a safety requirement for antibody-based therapies, ...

[Webinar]Towards IND: Specificity Profiling of Antibody Therapies Using the Membrane Proteome Array

[Webinar]Towards IND: Specificity Profiling of Antibody Therapies Using the Membrane Proteome Array

Learn about using the

Membrane Protein Identification by Shotgun Proteomics

Membrane Protein Identification by Shotgun Proteomics

Membrane proteins

R&D Systems®: Proteome Profiler Antibody Array 실험과정 (공식대리점: 웅비메디텍)

R&D Systems®: Proteome Profiler Antibody Array 실험과정 (공식대리점: 웅비메디텍)

Bio-Techne®의 공식 한국대리점인 웅비메디텍을 통해 R&D Systems®의 다양한 Multiplex 제품들을 만나보세요.

100+ Undruggable Targets Unlocked Through Parallel MAb Engineering

100+ Undruggable Targets Unlocked Through Parallel MAb Engineering

... optimize affinity, developability, and IP breadth at once, and presents

[GEN Webinars] Towards IND: Specificity Profiling of Antibody-Based Therapies

[GEN Webinars] Towards IND: Specificity Profiling of Antibody-Based Therapies

Rigorous specificity analysis is critical for successful drug development and a safety requirement for monoclonal antibody (mAb) ...

Ab Development to IND: Early Risk Mitigation, Target Specificity, & mRNA-LNP Delivery

Ab Development to IND: Early Risk Mitigation, Target Specificity, & mRNA-LNP Delivery

Traditional pathways for antibody IND submission often overlook opportunities to mitigate

Lecture 12, concept 05: Membrane proteins are some of the most common drug targets

Lecture 12, concept 05: Membrane proteins are some of the most common drug targets

... then we keep having a bunch of additional

Efficient and convenient enrichment of multispanning membrane proteins for proteomic studies

Efficient and convenient enrichment of multispanning membrane proteins for proteomic studies

https://www.thermofisher.com/us/en/home/about-us/events/life-science/7-steps-